Sequoia Financial Advisors LLC lessened its holdings in Danaher Corporation (NYSE:DHR) by 1.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,365 shares of the conglomerate’s stock after selling 44 shares during the period. Sequoia Financial Advisors LLC’s holdings in Danaher Corporation were worth $200,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Peddock Capital Advisors LLC raised its position in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares during the last quarter. Proficio Capital Partners LLC increased its position in Danaher Corporation by 92.3% during the first quarter. Proficio Capital Partners LLC now owns 1,246 shares of the conglomerate’s stock worth $105,000 after purchasing an additional 598 shares during the last quarter. ClariVest Asset Management LLC acquired a new position in Danaher Corporation during the first quarter worth approximately $157,000. Motco increased its position in Danaher Corporation by 8.8% during the second quarter. Motco now owns 2,011 shares of the conglomerate’s stock worth $170,000 after purchasing an additional 163 shares during the last quarter. Finally, Cornerstone Advisors Inc. increased its position in Danaher Corporation by 62.0% during the second quarter. Cornerstone Advisors Inc. now owns 2,111 shares of the conglomerate’s stock worth $178,000 after purchasing an additional 808 shares during the last quarter. 75.68% of the stock is currently owned by institutional investors.

DHR has been the subject of several research analyst reports. J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $95.00 price target on shares of Danaher Corporation in a research report on Friday, September 8th. BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Saturday, July 8th. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Citigroup Inc. set a $96.00 price target on shares of Danaher Corporation and gave the stock a “buy” rating in a research report on Friday, July 21st. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $88.00 price target on shares of Danaher Corporation in a research report on Wednesday, July 12th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. Danaher Corporation has an average rating of “Buy” and a consensus target price of $92.62.

COPYRIGHT VIOLATION NOTICE: “Sequoia Financial Advisors LLC Sells 44 Shares of Danaher Corporation (DHR)” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/sequoia-financial-advisors-llc-sells-44-shares-of-danaher-corporation-dhr/1614441.html.

In other news, insider William King sold 43,688 shares of Danaher Corporation stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the transaction, the insider now owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of Danaher Corporation stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now directly owns 155,520 shares in the company, valued at approximately $12,718,425.60. The disclosure for this sale can be found here. In the last three months, insiders sold 71,496 shares of company stock worth $5,916,223. Insiders own 12.20% of the company’s stock.

Shares of Danaher Corporation (NYSE:DHR) opened at 87.63 on Friday. The stock has a 50 day moving average of $85.07 and a 200 day moving average of $84.19. The firm has a market cap of $60.88 billion, a price-to-earnings ratio of 27.97 and a beta of 1.03. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.62.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same quarter last year, the firm earned $0.90 earnings per share. Equities analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 29th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s dividend payout ratio is 17.83%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.